This department is offering a grant to promote the discovery and validation of novel therapeutic targets for the development of safe and effective pain treatments. The focus is on identifying targets in the nervous and immune systems with minimal side effects and low abuse potential. Research should include rigorous validation studies to demonstrate the target’s effectiveness. Projects for various pain conditions like acute pain, chronic pain, migraine, neuropathies, and post-stroke pain are encouraged. The grant aims to support basic science studies to identify targets for developing new pain treatments, excluding medical devices. Application deadline is Nov 12, 2019.
Opportunity ID: 309099
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-NS-18-043 |
Funding Opportunity Title: | Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Food and Nutrition Health Income Security and Social Services |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 19, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | Nov 12, 2019 |
Current Closing Date for Applications: | Nov 12, 2019 |
Archive Date: | Dec 18, 2019 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Independent school districts Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Native American tribal organizations (other than Federally recognized tribal governments) State governments County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Public housing authorities/Indian housing authorities |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics. Specifically, the focus of this FOA is on the basic science discovery of targets in the peripheral nervous system, central nervous system, immune system or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability. Research supported by this FOA must include rigorous validation studies to demonstrate the robustness of the target as a pain treatment target. This will lower the risk of adopting the target in translational projects to develop small molecules, biologics, natural substances, or devices that interact with this target for new pain treatments. Translational research to develop new medical devices are not the focus of this FOA. Basic science studies of pain and related systems in the body are responsive to this FOA and are encouraged in the context of novel pain therapeutic target discovery. This FOA is not specific for any one or group of pain conditions. Projects to identify novel targets for acute pain, chronic pain, migraine, other headache disorders, osteoarthritis, diabetic neuropathy, chemotherapy-induced neuropathy, sickle-cell pain, post stroke pain, etc. will be considered. Projects to identify novel targets for a combination of chronic overlapping pain conditions or for specific pathological conditions will be considered. Projects that seek to identify novel targets in specific populations such as women, children, older adults or other underrepresented groups will also be responsive to this FOA. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-043.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | FORMS-E | PKG00244971 | Oct 27, 2018 | Nov 12, 2019 | View |
Package 1
Mandatory forms
309099 RR_SF424_2_0-2.0.pdf
309099 PHS398_CoverPageSupplement_4_0-4.0.pdf
309099 RR_OtherProjectInfo_1_4-1.4.pdf
309099 PerformanceSite_2_0-2.0.pdf
309099 RR_KeyPersonExpanded_2_0-2.0.pdf
309099 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
309099 RR_Budget_1_4-1.4.pdf
309099 RR_SubawardBudget30_1_4-1.4.pdf
309099 PHS398_ModularBudget_1_2-1.2.pdf
309099 PHS_AssignmentRequestForm_2_0-2.0.pdf